|
2024
|
G/S
|
Downloadable and recorded computer software platforms using artificial intelligence for automated... |
|
|
Invention
|
Pharmaceutical formulations for inhalation and uses thereof. Provided herein are pharmaceutical f... |
|
|
Invention
|
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) inhibitor combinations and uses thereo... |
|
|
Invention
|
Crystalline tnik inhibitor and uses thereof. Described herein are crystalline forms of a TNIK inh... |
|
|
Invention
|
Substituted thiazole compounds as cdk2/4/6 inhibitors and methods of use thereof. The disclosure ... |
|
|
Invention
|
Synthesis of macrocyclic compound and medical use of macrocyclic compound. Provided in the presen... |
|
|
Invention
|
Kras inhibitors and uses thereof. KRAS mutation inhibitors and pharmaceutical compositions compri... |
|
|
Invention
|
Prmt5 inhibitors and uses thereof. Provides for compounds and compositions for modulating or inhi... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors and uses thereof. Described herein are NOD-like receptor protein 3 ... |
|
|
Invention
|
Spiro derivatives as wrn inhibitors. Provided compounds of Formula (I) or pharmaceutically accept... |
|
|
Invention
|
Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof. The disclosur... |
|
|
G/S
|
Computers; Computer software applications, downloadable; Mobile phone software applications, down... |
|
|
Invention
|
Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof. Des... |
|
|
Invention
|
Crystalline prolyl hydroxylase domain-containing protein (phd) inhibitor and uses thereof. Crysta... |
|
|
Invention
|
Crystalline prolyl hydroxylase domain-containing protein (phd) inhibitor and uses thereof. Descri... |
|
|
Invention
|
Crystalline sars-cov-2 inhibitor and uses thereof. Described herein are crystalline forms of a sm... |
|
|
Invention
|
Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof. Described herein are ... |
|
|
Invention
|
Lysine acetyltransferase 6a (kat6a) inhibitor, combinations and uses thereof. Described herein ar... |
|
|
Invention
|
Crystalline methionine adenosyltransferase 2a (mat2a) inhibitor and uses thereof. Described herei... |
|
|
Invention
|
Methionine adenosyltransferase 2a (mat2a) inhibitor combinations and uses thereof. Described here... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors and uses thereof. Described herein are NLRP3 inflammasome inhibitor... |
|
|
Invention
|
Inhibitors of fgfr2 and fgfr3 and uses thereof. Described herein are FGFR2 and FGFR3 inhibitors a... |
|
|
Invention
|
Cdk8/19 dual inhibitors and methods of use thereof. The disclosure provides for compounds and met... |
|
|
Invention
|
Pro inhibitors for treating coronavirus infections. Provided herein are compounds, pharmaceutical... |
|
|
G/S
|
Downloadable and recorded computer software; recorded or downloadable computer software platforms... |
|
|
G/S
|
Downloadable computer software applications for estimating the relative binding free energy to pr... |
|
|
Invention
|
Inhibitors of kif18a and uses thereof. Described herein are KIF18A inhibitors and pharmaceutical ... |
|
2023
|
Invention
|
Protein tyrosine phosphatase inhibitors and uses thereof. Provided are compounds, methods for mod... |
|
|
Invention
|
Spirocyclic hpk1 antagonists and uses thereof. Described herein are spirocyclic HPK1inhibitors an... |
|
|
Invention
|
Cbl-b inhibitors and methods of uses thereof. The disclosure provides for compounds and methods f... |
|
|
Invention
|
Salt-inducible kinases (sik) inhibitors and methods of uses thereof. The disclosure provides for ... |
|
|
Invention
|
Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof. Described... |
|
|
Invention
|
Tead inhibitors and methods of uses thereof. Provided herein are compounds and methods for modula... |
|
|
Invention
|
Inhibitors of trex1 and uses thereof. Described herein are TREX1 inhibitors and pharmaceutical co... |
|
|
Invention
|
Methods of manufacturing kinase inhibitors. In one aspect, the disclosure provides methods of syn... |
|
|
Invention
|
Inhibitors of cyclin-dependent kinase (cdk) 12 and/or cdk13 and uses thereof. Described herein ar... |
|
|
Invention
|
Cbl-b inhibitors and methods of uses thereof. Provided for compounds and methods for modulating o... |
|
|
Invention
|
Inhibitors of fgfr2 and fgfr3 and uses thereof. Provided are FGFR2 and FGFR3 inhibitors of Formul... |
|
|
Invention
|
Hpk1 antagonists and uses thereof. Described herein are HPK1inhibitors and pharmaceutical composi... |
|
|
Invention
|
Pyrazole membrane-associated tyrosine-and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhi... |
|
|
Invention
|
Heteroaromatic compounds as pkmyt1 inhibitors and use thereof. Providing compounds of Formula (A)... |
|
|
Invention
|
Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof. Described herein are DGKalpha inhi... |
|
|
Invention
|
Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof. Provided are DGKalpha inhibitors a... |
|
|
Invention
|
Structure-based deep generative model for binding site descriptors extraction and de novo molecul... |
|
|
Invention
|
Membrane-associated tyrosine-and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors an... |
|
|
Invention
|
Local steps in latent space and descriptors-based molecules filtering for conditional molecular g... |
